Why Do I Need Adjuvant Therapy? Communicating the Risks for HR-Positive, HER2-Negative EBC at High Risk of Recurrence

Keeping Current CME

English - December 18, 2023 16:50 - 17 minutes - 16.8 MB - ★★★★ - 22 ratings
Science Health & Fitness Medicine Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Understanding the Concerns and Challenges of Patients With HR-Positive/HER2-Negative EBC: Expert Insights and Recommendations

Next Episode: Confronting Obesity in Cardiology Care: A Major Driver of Cardiovascular Risk

Your patient has endured surgery, radiation therapy, and chemotherapy. After all that, how do you discuss the risk of recurrence and additional treatment?

Credit available for this activity expires: 12/15/2024
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999193?ecd=bdc_podcast_libsyn_mscpedu